講演者

John L. Allinson, FIBMS, Vice President, Biomarker Laboratory Services, ICON Development Solutions

Philip Askenase, M.D., Professor, Immunology, Yale University School of Medicine

Jiri Aubrecht, Pharm.D., Ph.D., Senior Director and Safety Biomarker Group Lead, Drug Safety Research & Development, Pfizer

Finley Austin, Ph.D., Personalized Healthcare and Biomarker Strategy Director, AstraZeneca

Nazneen Aziz, Ph.D., Director of Molecular Medicine, Transformation Program Office, College of American Pathologists

Haifeng Bao, Ph.D., Research & Development, Translational Sciences, MedImmune

William Barsan, M.D., Principal Investigator, NETT Clinical Coordinating Center, Neurologic Emergencies Treatment Trials Network

Jeremy Barton, M.D., Vice President, Head of Oncology Clinical Research, Pfizer

Lyudmila Bazhenova, M.D., Associate Clinical Professor, Medicine, Division of Hematology-Oncology; Lung Cancer Team Leader, Moores UCSD Cancer Center

Robert A. Beckman, M.D., Executive Director, Clinical Development Oncology, Daiichi Sankyo Pharma Development

John F. Beeler, Ph.D., Director, Theranostics and Business Development, bioMerieux

Donald Berry, Ph.D., Professor and Head, Quantitative Sciences, MD Anderson Cancer Center

Rhonda L. Bitting, M.D., Instructor, Department of Medicine, Duke Cancer Institute

Jean-Pierre Bizzari, M.D., Senior Vice President, Clinical Oncology/Hematology, Celgene Corporation

Daniel Boffa, M.D., Assistant Professor of Surgery, Yale School of Medicine

Xandra Breakefield, Ph.D., Professor, Neurology, Harvard Medical School; Geneticist, Molecular Neurogenetics, Massachusetts General Hospital

Linda Burdette, Ph.D., Director, Drug Regulatory Affairs, Hoffmann-La Roche

Patricia Burke, Ph.D., Scientist, Translational Medicine Oncology, MedImmune

Devon C. Campbell, Director, Engineering and Systems, Novartis Molecular Diagnostics

Preston W. Campbell, III, M.D., Executive Vice President for Medical Affairs, Cystic Fibrosis Foundation

Jeffrey Chalmers, Ph.D., Professor, Chemical and Biomolecular Engineering, Ohio State University

Richard A. Cerione, Ph.D., Professor, Molecular Medicine, Cornell University

Peter Choyke, M.D., F.A.C.R., Chief, Molecular Imaging Program, National Cancer Institute, National Institutes of Health

Joshua P. Cohen, Ph.D., Senior Research Fellow, Tufts Center for the Study of Drug Development

Carolyn Compton, M.D., Ph.D., President & CEO, Critical Path Institute

Bryan Dechairo, Ph.D., Head, Extramural Research & Development, Medco Research Institute

Viswanath Devanarayan, Ph.D., Director, Exploratory Statistics, Abbott Laboratories

Vlad Dragalin, Ph.D., Senior Vice President, Innovation Center, Aptiv Solutions

Crislyn D'Souza-Schorey, Ph.D., Professor, Biological Sciences, University of Notre Dame

Jens C. Eickhoff, Ph.D., Senior Scientist, Biostatistics and Medical Informatics, University of Wisconsin

Guo-Chang Fan, Ph.D., Assistant Professor, Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine

Reyna Favis, Ph.D., Scientific Director and Head, Neuroscience Biomarkers Laboratory, Janssen Pharmaceutical Companies of Johnson & Johnson

Andrea Ferreira-Gonzalez, Ph.D., Professor and Chair, Division of Molecular Diagnostics; Director, Molecular Diagnostics Laboratory, Department of Pathology, Virginia Commonwealth University

Martin Fleisher, Ph.D., Chief, Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center

Herbert A. Fritsche, Ph.D., Senior Vice President and CSO, Health Discovery Corporation

Alessia Gallo, Ph.D., Fellow, Molecular Physiology and Therapeutics Branch, NIDCR, National Institutes of Health

Christine Gathers, M.S., RAC, Senior Director, Global Regulatory Affairs, Diagnostics, Eli Lilly and Company

Ghideon Ghebregiorgis, Ph.D., Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration

Oscar Goodman, Jr., M.D., Ph.D., Medical Director, Clinical Trials Office, UC San Diego Nevada Cancer Institute

Federico Goodsaid, Ph.D., Vice President, Strategic Regulatory Intelligence, Vertex Pharmaceuticals

Michael Graner, Ph.D., Associate Professor, Neurosurgery, University of Colorado School of Medicine

Andrew Grupe, Ph.D., Senior Director, Pharmacogenomics, Celera/Quest Diagnostics

Abdel Halim, Pharm.D., Ph.D., DABCC-MDx, DABCC-TOX, DABCC-CC, FACB, Director, Clinical Biomarkers, Daiichi Sankyo Pharma Development

Samir Hanash, M.D., Ph.D., Program Head, Molecular Diagnostics, Fred Hutchinson Cancer Research Center

Madhuri Hegde, Ph.D., Associate Professor, Human Genetics; Senior Director, Emory Genetics Laboratory, Emory University

Holly Hilton, Ph.D., Head, Disease and Translational Genomics, F. Hoffmann-La Roche

Dave S. B. Hoon, M.Sc., Ph.D., Director, Molecular Oncology, John Wayne Cancer Institute

Jason C. Hsu, Ph.D., Professor, Statistics, The Ohio State University

Mingxiu Hu, Ph.D., ASA Fellow, Head, Biostatistics and Statistical Programming, Millennium: The Takeda Oncology Company

Paula M. Jacobs, Ph.D., Associate Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health

Muthuvel Jayachandran, Ph.D., Associate Professor, Physiology and Biomedical Engineering, College of Medicine, Mayo Clinic

J. Milburn Jessup, M.D., Chief, Diagnostics Evaluation Branch, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health

Feng Jiang, M.D., Ph.D., Associate Professor, Pathology, University of Maryland School of Medicine

Scott Kennedy, Ph.D., Global Head, Biomarker Development, Novartis Institutes for BioMedical Research, Inc.

Paul Kildal-Brandt, Business Alliances and Development Leader, Janssen Diagnostics

Brian J. Kirby, Ph.D., Associate Professor, Sibley School of Mechanical and Aerospace Engineering, Cornell University; Associate Professor of Engineering in Medicine, Division of Hematology and Oncology, Weill-Cornell Medical College

Mark A. Knepper, M.D., Ph.D., Chief, Epithelial Systems Biology Group, Laboratory of Kidney and Electrolyte Metabolism, National Heart Lung and Blood Institute, National Institutes of Health

Walter H. Koch, Ph.D., Vice President and Head of Global Research, Roche Molecular Diagnostics

Maria Koehler, M.D., Ph.D., Vice President, Tumor Strategy; Clinical Development and Medical Affairs, Oncology Business Unit, Pfizer

Geert Kolvenbag, M.D., Ph.D., Global Product Vice President, AstraZeneca

Peter Kurre, M.D., Associate Professor, Pediatrics, Oregon Stem Cell Center, Department of Pediatrics and Cell & Developmental Biology, Oregon Health & Science University

Shiowjen Lee, Ph.D., Acting Team Lead, Division of Biostatistics, Office of Biostatistics and Epidemiology, CBER, FDA

Aiguo Li, Ph.D., Senior Bioinformatician, NOB, National Cancer Institute, National Institutes of Health

Sai Kiang Lim, Ph.D., Principal Investigator, Institute of Medical Biology, A-Star, Singapore; Research Associate Professor, Surgery, Yong Loo Lin School of Medicine, National University of Singapore

Julie Lisano, Ph.D., Director, Clinical Science, Oncology, Regeneron Pharmaceuticals

Kenneth Liu, Ph.D., Associate Director, Merck & Company

Johan Luthman, D.D.S., Ph.D., Senior Program Leader, Neuroscience and Ophthalmology Research & Development, Merck & Co., Inc.

David Lyden, M.D., Ph.D., Associate Professor, Pediatrics, Weill Medical College of Cornell University

Sabah Malek, Senior Regulatory Scientist, IVD/Medical Devices, Voisin Consulting Life Sciences

Kathleen A. Mandziuk, M.P.H., R.N., Senior Scientific Affairs Director, Late Phase Services, PRA International

David Manner, Ph.D., Group Leader, Endocrine Exploratory and Program Medical Statistics, Eli Lilly & Co

Dario Marchetti, Ph.D., Professor, Pathology and Immunology, Baylor College of Medicine

Theo McCormick, Director, RxDx Services, Management Science Associates, Inc.

Paul J. McCracken, Ph.D., Director of Imaging, Biomarkers and Personalized Medicine CFU, Eisai, Inc.

Michael Merz, M.D., Director, Preclinical Safety, Translational Sciences, Novartis Institutes for BioMedical Research

Giacomo Mordenti, Senior Expert Biotatistician, Global Biostatistics, Merck Serono S.A.

Monica Motwani, Ph.D., Director, Oncology Biomarkers, GlaxoSmithKline

Günter Müller, Ph.D., Research & Development, Diabetes Division, Obesity Strategy Team, Sanofi Pharma Germany, Frankfurt am Main

Aaron Nelson, M.D., Ph.D., Senior investigator II, Translational Sciences, Novartis Institutes for Biomedical Research

Andrew B. Nixon, Ph.D., M.B.A., Assistant Professor, Medicine and Medical Oncology; Co-Director, Phase I Biomarker Laboratory, Duke University Medical Center

Robert Noble, Ph.D., Director, Statistics, GlaxoSmithKline

David Ohlssen, Ph.D., Senior Expert Methodologist, IIS Statistical Methodology, Novartis Pharmaceuticals

Sonia Pearson-White, Ph.D., Scientific Program Manager, Oncology, The Biomarkers Consortium, Foundation for the National Institutes of Health

Hans Christian Pedersen, M.Sc., Department Manager Research & Development, IHC pharmDx, Dako Denmark

Gene Pennello, Ph.D., Team Leader, Division of Biostatistics, U.S. Food and Drug Administration

Eric D. Perakslis, Ph.D., CIO and Chief Scientist, Informatics, U.S. Food and Drug Administration

Itay Perlstein, Ph.D., Associate Director, Clinical Pharmacology and Pharmacometrics, Discovery Medicine and Clinical Pharmacology, Bristol-Myers Squibb

Emanuel Petricoin III, Ph.D., Co-Director, The Center for Applied Proteomics and Molecular Medicine, George Mason University

Margaret Piper, Ph.D., M.P.H., Director of Genomics Resources, Technology Evaluation Center, Blue Cross Blue Shield Association

Suso Platero, Ph.D., Director, Oncology Biomarkers, Janssen Pharmaceuticals

Judith Quinlan, Senior Vice President, Innovations Center, Aptiv Solutions

Rachel E. Raab, M.D., Assistant Professor, Medicine, Brody School of Medicine, East Carolina University

Janusz Rak, M.D., Ph.D., Professor, Pediatrics, Montreal Children's Hospital Research Institute, McGill University

Mariusz Ratajczak, M.D., Ph.D., D.Sci., Professor, Medicine; Director, Developmental Biology Research Program, University of Louisville

Monica Reinholz, Ph.D., Senior Manager, Biomarker Strategy; Director, Clinical Studies, Translational Diagnostics, Ventana Medical Systems

Leonard Reyno, M.D., CMO, Agensys, Inc., Affiliate of Astellas Pharma

Paul Rhyne, Ph.D., Senior Director, Tandem Labs

Gavin P. Robertson, Ph.D., Professor, Pharmacology, Pathology, Dermatology and Surgery, Penn State University; Director, Penn State Melanoma Center, Penn State Melanoma Therapeutics Program, and Foreman Foundation Melanoma Research Laboratory

Paul D. Robbins, Ph.D., Professor, Metabolism and Aging, The Scripps Research Institute

Henry Rodriguez, Ph.D., M.B.A., Director, Office of Cancer Clinical Proteomics Research, National Cancer Institute

Donna Roscoe, Ph.D., Senior Scientific Reviewer, Center for Devices and Radiological Health, Office of In Vitro Diagnostic Device Evaluation, Division of Immunology and Hematology Devices, U.S. Food and Drug Administration

Daniel P. Rossignol, Ph.D., Executive Director, Taisho Pharmaceutical Research & Development

Somnath Sarkar, Ph.D., Director, Oncology Biomarkers, Genentech

Raymond M. Schiffelers, Ph.D., Associate Professor, Laboratory Clinical Chemistry and Hematology, University Medical Center Utrecht

Cecilia Schott, Pharm.D., M.B.A., Executive Business Development Director, Personalized Healthcare, AstraZeneca

Paola Sebastiani, Ph.D., Professor, Biostatistics, Boston University

Paulina Selaru, M.S., M.S.P.H., Director, Xalkori Statistical Lead, Oncology Business Unit, Pfizer

Sushma Selvarajan, Ph.D., Head, Business Development and Strategy, Roche Molecular Systems

David Shalinsky, Ph.D., Senior Principal Research Scientist, Abbott Laboratories

Shivani Sharma, Ph.D., Project Scientist, California Nanosystems Institute, UCLA

Mei-Chiung Shih, Ph.D., Senior Biostatistician, VA Palo Alto Cooperative Studies Program Coordinating Center; Assistant Professor, Health Research and Policy, Stanford University

Giselle Sholler, M.D., M.Sc., Associate Professor; Co-Director, Pediatric Oncology Translational Research Program, VAI/TGen; Haworth Family Director, Innovative Therapeutics Clinic, Helen DeVos Children's Hospital; Chair, Neuroblastoma and Medulloblastoma Translational Research Consortium

Yu Shyr, Ph.D., Director, Vanderbilt Center for Quantitative Sciences; Ingram Distinguished Professor of Cancer Research; Associate Director, Vanderbilt-Ingram Cancer Center; Professor, Biostatistics, Biomedical Informatics, Cancer Biology and Preventive Medicine, Vanderbilt University School of Medicine

Richard M. Simon, Ph.D., Chief, Biometric Research Branch, National Cancer Institute

Corinne Solier, Ph.D., Group Head, Clinical Protein Biomarkers, F. Hoffmann-La Roche

Sudhir Srivastava, Ph.D., Chief, Cancer Biomarkers Research Group, National Cancer Institute

Shannon Stott, Ph.D., Research Fellow, Surgery, Massachusetts General Hospital, Harvard Medical School

Edith Szafer-Glusman, Ph.D., Senior Research Associate, Development Sciences, Genentech

Joseph D. Szustakowski, Ph.D., Senior Group Head, Translational Medicine, Biomarker Development, and Bioinformatics, Novartis Institutes for Biomedical Research

Ian Taylor, Ph.D., Senior Director, Translational Oncology, Pfizer

Anjan Thakurta, Ph.D., Senior Director, Translational Development Integration, Celgene

Hsian-Rong Tseng, Ph.D., Associate Professor, Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, UCLA

Apostolia-Maria Tsimberidou, M.D., Ph.D., Associate Professor, Investigational Cancer Therapeutics, University of Texas, MD Anderson Cancer Center

Gerrit van Roekel, Director, Business Development, Diagnostics Division, Abbott Laboratories

Robert L. Vessella, Ph.D., Professor; Pritt Family Chair, Translational Prostate Cancer Research; Director, Genitourinary Cancer Research Laboratory, Department of Urology, University of Washington Medical Center

John Viator, Ph.D., Associate Professor, Biological Engineering, University of Missouri

Lihua Wang, Ph.D., Senior Scientist, PADIS, LHTP, Applied Developmental Directorate, SAIC-Frederick, NCI/NIH

Susan E. Ward, Ph.D., Senior Clinical Program Leader, Translational and Experimental Medicine, Biogen Idec

Amelia Warner, Ph.D., Director, Clinical Pharmacogenomics, Merck

Pamela Wearsch, Ph.D., Assistant Professor, Pathology, Case Western Reserve University

Mary Steele Williams, Executive Director, Association for Molecular Pathology

Alan Wookey, Executive Director, Companion Diagnostics, LabCorp Clinical Trials, Laboratory Corporation of America

Alan Xiao, Ph.D., Senior Pharmacometrician, Clinical Science, AstraZeneca

Eric Yang, Ph.D., Informatics Scientist, Informatics COE, Johnson & Johnson

Ying Yuan, Ph.D., Associate Professor, Biostatistics, University of Texas MD Anderson Cancer Center

Peter S. T. Yuen, Ph.D., Staff Scientist, Renal Diagnostics and Therapeutics Unit, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health

Huang-Ge Zhang, M.D., D.V.M., Ph.D., Professor, Microbiology and Immunology, University of Louisville